R&D Changing Faces: Pharma and biotech hires, September 2026 There was plenty of movement at the top of pharma and biotech in September, with leadership changes spanning some of the industry’s biggest names.
R&D Changing Faces: Board of Director and Advisory Board hires, ... Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August.
Digital Changing Faces: Digital and supplier hires, August 2026 Digital health, clinical technology, contract services, and life sciences suppliers all saw notable leadership changes last month.
R&D Changing Faces: Pharma and biotech hires, August 2026 August brought another wave of leadership changes across biotech, pharma, and research organisations.
R&D Changing Faces: Board appointments, June and July 2026 Board appointments June/July brought together veterans from across the pharmaceutical industry, venture capital, healthcare technology, and academia
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires, Jun... Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.